Ultragenyx Pharmaceutical Inc (RARE)
43.85
-0.43
(-0.97%)
USD |
NASDAQ |
Apr 25, 16:00
43.85
0.00 (0.00%)
After-Hours: 16:57
Ultragenyx Pharmaceutical Total Return Price: 43.85 for April 25, 2024
Total Return Price Chart
Historical Total Return Price Data
Date | Value |
---|---|
April 24, 2024 | 44.28 |
April 23, 2024 | 45.11 |
April 22, 2024 | 43.69 |
April 19, 2024 | 42.37 |
April 18, 2024 | 43.38 |
April 17, 2024 | 44.11 |
April 16, 2024 | 42.31 |
April 15, 2024 | 42.87 |
April 12, 2024 | 47.00 |
April 11, 2024 | 50.70 |
April 10, 2024 | 51.61 |
April 09, 2024 | 50.56 |
April 08, 2024 | 50.23 |
April 05, 2024 | 50.24 |
April 04, 2024 | 47.08 |
April 03, 2024 | 47.08 |
April 02, 2024 | 46.59 |
April 01, 2024 | 46.97 |
March 28, 2024 | 46.69 |
March 27, 2024 | 46.82 |
March 26, 2024 | 45.46 |
March 25, 2024 | 45.42 |
March 22, 2024 | 45.85 |
March 21, 2024 | 46.65 |
March 20, 2024 | 47.01 |
Date | Value |
---|---|
March 19, 2024 | 47.00 |
March 18, 2024 | 46.59 |
March 15, 2024 | 47.37 |
March 14, 2024 | 46.65 |
March 13, 2024 | 48.55 |
March 12, 2024 | 47.66 |
March 11, 2024 | 48.51 |
March 08, 2024 | 50.53 |
March 07, 2024 | 50.85 |
March 06, 2024 | 51.26 |
March 05, 2024 | 51.47 |
March 04, 2024 | 53.31 |
March 01, 2024 | 53.69 |
February 29, 2024 | 51.72 |
February 28, 2024 | 52.75 |
February 27, 2024 | 53.66 |
February 26, 2024 | 50.25 |
February 23, 2024 | 49.48 |
February 22, 2024 | 48.88 |
February 21, 2024 | 48.18 |
February 20, 2024 | 47.87 |
February 16, 2024 | 48.92 |
February 15, 2024 | 46.26 |
February 14, 2024 | 45.66 |
February 13, 2024 | 43.98 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
31.73
Minimum
Oct 18 2023
177.39
Maximum
Dec 23 2020
66.04
Average
57.20
Median
Total Return Price Benchmarks
Corcept Therapeutics Inc | 22.21 |
Madrigal Pharmaceuticals Inc | 194.36 |
Sarepta Therapeutics Inc | 127.36 |
FibroGen Inc | 1.015 |
Rocket Pharmaceuticals Inc | 22.11 |